The uninsured rate among US adults aged 19 to 64 years rose from 8.9% in 2024 to 11.2% in 2026, a statistically significant ...

The US has curative HCV treatment and rapid tests but lags peer nations in prevention for people who inject drugs. The US is ...

Brensocatib hydrate (Brinsupri; Insmed Inc) launched commercially in Japan on October 19 for adults and children 12 years and ...

Myeloma faculty from UT Southwestern Medical Center and pharmacy leaders from Texas Oncology discussed how teclistamab- and ...

Samantha Pettigrew, MD, explains blood clot risk factors, treatment, and return to play in the wake of the news of Jalen ...

People with arrhythmogenic cardiomyopathy (ACM) may face increased risk of ventricular arrhythmias and worsening heart ...

Universal HCV testing in pregnancy, DAA therapy, and earlier infant RNA testing can curb mother-to-child hepatitis C ...

The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, ...

Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an ...

Pharmacies are an emerging setting. In a claims analysis covering 2010 to 2017, pharmacists administered a small share of ...

Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates. Nearly a third of ...

Infectious disease research and training partnerships should shift from donor-recipient models toward shared, locally led ...